𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation

✍ Scribed by Rauf Haznedar; Münci Yağcı

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
166 KB
Volume
69
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis

Letters and correspondence submitted for possible publication must be identi®ed as such. Text length must not exceed 500 words and ®ve bibliographic references. A single concise ®gure or table may be included if it is essential to support the communication. Letters not typed double-spaced will not be considered for publication. Letters not meeting these speci®cations will not be returned to authors. Letters to the Editor are utilized to communicate a single novel observation or ®nding. Correspondence is to be used to supplement or constructively comment on the contents of a publication in the journal and cannot exceed the restrictions for Letters to the Editor. The Editor reserves the right to shorten text, delete objectional comments, and make other changes to comply with the style of the journal. Permission for publication must be appended as a postscript. Submissions must be sent to

📜 SIMILAR VOLUMES

Successful long-term control with lamivu
Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: Experience of 2 cases
✍ Masashi Nakagawa; Yoshifumi Simizu; Masaki Suemura; Bunzo Sato 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## Abstract It is well documented that cytotoxic treatment in patients carrying the hepatitis B virus (HBV) enhances the risk of severe hepatic damage. Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions. Here we report two cases with HB

Autologous bone marrow versus non-mobili
Autologous bone marrow versus non-mobilized peripheral blood stem cell transplantation for lymphoid malignancies: A prospective, comparative trial
✍ Weisdorf, Daniel J.; Verfaillie, Catherine M.; Miller, Wesley J.; Blazar, Bruce 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

## Autologous transplantation using bone marrow stem cells (BMSC) or peripheral blood stem cells (PBSC) is widely used for non-Hodgkin 's lymphoma (NHL) and Hodgkin's disease (HD). We report a randomized, comparative trial comparing BMSC vs. nonmobilized PBSC for responsive NHL or HD. Patients ran

High-dose therapy and autologous periphe
High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients
✍ Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia Praticò; Caterina Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplant‐related mortality. We evaluated the combination of high‐dose therapy and autologous peripheral blood stem cel